Ocugen (OCGN) Amortizatization of Intangibles (2017 - 2023)

Ocugen (OCGN) reported Amortizatization of Intangibles of $39000.0 for Q2 2023, down 72.73% quarter-over-quarter from $143000.0 in Q1 2023.

Ocugen (OCGN) Amortizatization of Intangibles (2017 - 2023) Analysis & Trends

Ocugen has reported Amortizatization of Intangibles for 3 years, with the latest figure at $39000.0 in Q2 2023.

For the quarter ending Q2 2023, Amortizatization of Intangibles changed N/A year-over-year to $39000.0; the trailing twelve-month figure through Mar 2024 stood at $39000.0 (down 83.88% YoY), and the FY2023 full-year result was $182000.0, up 83.84% from the prior year.
Amortizatization of Intangibles for Q2 2023 stood at $39000.0, down from $143000.0 in the prior quarter.
The five-year high for Amortizatization of Intangibles was $143000.0 in Q1 2023, with the low at $39000.0 in Q2 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Amortizatization of Intangibles (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	13,267.00
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Ocugen	411.07 Mn	411.07 Mn	-	-

Download Data